Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Pregnant or breastfeeding women should avoid AOD-9604 due to lack of safety data in these populations
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
Many are manufactured overseas, outside of FDA jurisdiction, which increases the risk of contamination or counterfeit ingredients. In addition, Dr
The clinical consequences could range from local inflammation or rash through to serious health issues, such as systemic hypersensitivity, including anaphylaxis, or antibody formation
It is more often discussed as a repair-focused compound because of its proposed effects on inflammation, tissue healing, angiogenesis, and mucosal protection
US$ 25.11
US$ 27.59
US$ 28.49
